Elevation Oncology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$45,704,000 over the previous period. Total operating expenses were $45,445,000.
Profit Margin
| 2019 | 0 | -5.88M | |
|---|---|---|---|
| 2020 | 0 | -17.26M | |
| 2021 | 0 | -32.03M | |
| 2022 | 0 | -95.08M | |
| 2023 | 0 | -45.70M |
ELEV Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 39K | 27K | 18K | 15K | 0 |
Gross profit | -39K | -27K | -18K | -15K | 0 |
Operating exp. | |||||
Research and development | 25.43M | 78.71M | 23.59M | 15.47M | 5.33M |
Selling and marketing | 0 | 0 | 0 | 0 | 543.18K |
Total operating expenses | 45.44M | 94.54M | 32.04M | 17.27M | 5.88M |
Operating income | -45.44M | -94.54M | -32.04M | -17.27M | -5.88M |
Other income (expenses), net | -229K | -506K | 7K | 11K | -5.25M |
Income before tax | -45.67M | -95.05M | -32.03M | -17.26M | -5.88M |
Income tax expense | 30K | 25K | 0 | -191.29K | -8.82K |
Net income | -45.70M | -95.08M | -32.03M | -17.26M | -5.88M |
Earnings per share | |||||
Basic EPS | -1.34 | -4.09 | -1.38 | -0.73 | -0.25 |
Diluted EPS | -1.34 | -4.09 | -1.38 | -0.73 | -0.25 |
| Data source | Data source | Data source |